GAT Therapeutics
Baldiri I Reixac, 4
08028 Barcelona
ES
GAT Therapeutics
Foundation date
03/06/2019
Sector
#Biotechnology - TherapeuticsSubsector
Therapeutic areas
- #Cardiovascular
- #Diseases of the blood and blood-forming organs - immune disorders
- #Endocrine - nutritional and metabolic diseases
GAT Therapeutics is an early stage biopharma targeting fibrosis and age-related diseases.
Upcoming events
All events-
0712 '21
MedFIT 2021
Event by: Eurasanté -
0712 '21
BioFIT 2021
Event by: Eurasanté -
1301 '22
Latest news
More news-
SeptiCyte® RAPID receives 510(k) clearance by US FDA
Wednesday December 1st 2021
Read more
-
QbD and Inovigate launch Health to Market, a contract commercialization organization in life sciences
Wednesday December 1st 2021
Read more
-
Dimitrios Mantzilas joins Precirix as Chief Technology Officer
Wednesday December 1st 2021
Read more